カテゴリー： LP Information, 世界, 医療/バイオ

世界のブルセラアボルタスワクチン市場予測 2021年-2026年

【英語タイトル】Global Brucella Abortus Vaccine Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9458）・商品コード：LPI21MY9458
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：179
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「ブルセラアボルタスワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、DNAワクチン、サブユニットワクチン、ベクターワクチン、Bアボルタス組換え変異体、その他など、用途別には、牛、羊、豚、その他などにセグメント区分してまとめました。ブルセラアボルタスワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・ブルセラアボルタスワクチンの世界市場概要（サマリー）
・ブルセラアボルタスワクチンの企業別販売量・売上
・ブルセラアボルタスワクチンの企業別市場シェア
・ブルセラアボルタスワクチンの世界市場規模 2016年-2021年：種類別（DNAワクチン、サブユニットワクチン、ベクターワクチン、Bアボルタス組換え変異体、その他）
・ブルセラアボルタスワクチンの世界市場規模 2016年-2021年：用途別（牛、羊、豚、その他）
・ブルセラアボルタスワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・ブルセラアボルタスワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・ブルセラアボルタスワクチンのヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・ブルセラアボルタスワクチンの中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・ブルセラアボルタスワクチン市場の成長要因・課題・動向
・ブルセラアボルタスワクチンの世界市場予測 2021年-2026年
・ブルセラアボルタスワクチンの南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・ブルセラアボルタスワクチンのアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・ブルセラアボルタスワクチンのヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・ブルセラアボルタスワクチンの中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・ブルセラアボルタスワクチンの世界市場予測：種類別（DNAワクチン、サブユニットワクチン、ベクターワクチン、Bアボルタス組換え変異体、その他）
・ブルセラアボルタスワクチンの世界市場予測：用途別（牛、羊、豚、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Brucella Abortus Vaccine will have significant change from previous year. By the most conservative estimates of global Brucella Abortus Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Brucella Abortus Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Brucella Abortus Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
DNA Vaccines
Subunit Vaccines
Vector Vaccines
B. Abortus Recombinant Mutants
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Cattles
Sheep
Pigs
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Zoetis
CEVA
Merck Animal Health
Biovet
CAVAC
JOVAC
Merial
Colorado Serum Company
VECOL
Tecnovax
Indian Immunologicals
Vetal
Dollvet
Centro Diagnostico Veterinario
Onderstepoort Biological Products
Institute of Animal Health and Veterinary Biologicals
Biogenesis Bago
Instituto Rosenbusch
SYVA Laboratorios
CZ Veterinaria
Hester Biosciences
Qilu Animal Health

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brucella Abortus Vaccine Consumption 2016-2026
2.1.2 Brucella Abortus Vaccine Consumption CAGR by Region
2.2 Brucella Abortus Vaccine Segment by Type
2.2.1 DNA Vaccines
2.2.2 Subunit Vaccines
2.2.3 Vector Vaccines
2.2.4 B. Abortus Recombinant Mutants
2.2.5 Others
2.3 Brucella Abortus Vaccine Sales by Type
2.3.1 Global Brucella Abortus Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Brucella Abortus Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Brucella Abortus Vaccine Sale Price by Type (2016-2021)
2.4 Brucella Abortus Vaccine Segment by Application
2.4.1 Cattles
2.4.2 Sheep
2.4.3 Pigs
2.4.4 Others
2.5 Brucella Abortus Vaccine Sales by Application
2.5.1 Global Brucella Abortus Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Brucella Abortus Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Brucella Abortus Vaccine Sale Price by Application (2016-2021)

3 Global Brucella Abortus Vaccine by Company
3.1 Global Brucella Abortus Vaccine Sales Market Share by Company
3.1.1 Global Brucella Abortus Vaccine Sales by Company (2019-2021)
3.1.2 Global Brucella Abortus Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Brucella Abortus Vaccine Revenue Market Share by Company
3.2.1 Global Brucella Abortus Vaccine Revenue by Company (2019-2021)
3.2.2 Global Brucella Abortus Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Brucella Abortus Vaccine Sale Price by Company
3.4 Global Manufacturers Brucella Abortus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Brucella Abortus Vaccine Product Location Distribution
3.4.2 Players Brucella Abortus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Brucella Abortus Vaccine by Region
4.1 Global Brucella Abortus Vaccine by Region
4.1.1 Global Brucella Abortus Vaccine Sales by Region
4.1.2 Global Brucella Abortus Vaccine Revenue by Region
4.2 Americas Brucella Abortus Vaccine Sales Growth
4.3 APAC Brucella Abortus Vaccine Sales Growth
4.4 Europe Brucella Abortus Vaccine Sales Growth
4.5 Middle East & Africa Brucella Abortus Vaccine Sales Growth

5 Americas
5.1 Americas Brucella Abortus Vaccine Sales by Country
5.1.1 Americas Brucella Abortus Vaccine Sales by Country (2016-2021)
5.1.2 Americas Brucella Abortus Vaccine Revenue by Country (2016-2021)
5.2 Americas Brucella Abortus Vaccine Sales by Type
5.3 Americas Brucella Abortus Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Brucella Abortus Vaccine Sales by Region
6.1.1 APAC Brucella Abortus Vaccine Sales by Region (2016-2021)
6.1.2 APAC Brucella Abortus Vaccine Revenue by Region (2016-2021)
6.2 APAC Brucella Abortus Vaccine Sales by Type
6.3 APAC Brucella Abortus Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Brucella Abortus Vaccine by Country
7.1.1 Europe Brucella Abortus Vaccine Sales by Country (2016-2021)
7.1.2 Europe Brucella Abortus Vaccine Revenue by Country (2016-2021)
7.2 Europe Brucella Abortus Vaccine Sales by Type
7.3 Europe Brucella Abortus Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Brucella Abortus Vaccine by Country
8.1.1 Middle East & Africa Brucella Abortus Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Brucella Abortus Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Brucella Abortus Vaccine Sales by Type
8.3 Middle East & Africa Brucella Abortus Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Brucella Abortus Vaccine Distributors
10.3 Brucella Abortus Vaccine Customer

11 Global Brucella Abortus Vaccine Market Forecast
11.1 Global Brucella Abortus Vaccine Forecast by Region
11.1.1 Global Brucella Abortus Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Brucella Abortus Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Brucella Abortus Vaccine Forecast by Type
11.7 Global Brucella Abortus Vaccine Forecast by Application

12 Key Players Analysis
12.1 Zoetis
12.1.1 Zoetis Zoetis Company Information
12.1.2 Zoetis Brucella Abortus Vaccine Product Offered
12.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Zoetis Main Business Overview
12.1.5 Zoetis Latest Developments
12.2 CEVA
12.2.1 CEVA Company Information
12.2.2 CEVA Brucella Abortus Vaccine Product Offered
12.2.3 CEVA Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 CEVA Main Business Overview
12.2.5 CEVA Latest Developments
12.3 Merck Animal Health
12.3.1 Merck Animal Health Company Information
12.3.2 Merck Animal Health Brucella Abortus Vaccine Product Offered
12.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Merck Animal Health Main Business Overview
12.3.5 Merck Animal Health Latest Developments
12.4 Biovet
12.4.1 Biovet Company Information
12.4.2 Biovet Brucella Abortus Vaccine Product Offered
12.4.3 Biovet Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Biovet Main Business Overview
12.4.5 Biovet Latest Developments
12.5 CAVAC
12.5.1 CAVAC Company Information
12.5.2 CAVAC Brucella Abortus Vaccine Product Offered
12.5.3 CAVAC Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 CAVAC Main Business Overview
12.5.5 CAVAC Latest Developments
12.6 JOVAC
12.6.1 JOVAC Company Information
12.6.2 JOVAC Brucella Abortus Vaccine Product Offered
12.6.3 JOVAC Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 JOVAC Main Business Overview
12.6.5 JOVAC Latest Developments
12.7 Merial
12.7.1 Merial Company Information
12.7.2 Merial Brucella Abortus Vaccine Product Offered
12.7.3 Merial Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Merial Main Business Overview
12.7.5 Merial Latest Developments
12.8 Colorado Serum Company
12.8.1 Colorado Serum Company Company Information
12.8.2 Colorado Serum Company Brucella Abortus Vaccine Product Offered
12.8.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Colorado Serum Company Main Business Overview
12.8.5 Colorado Serum Company Latest Developments
12.9 VECOL
12.9.1 VECOL Company Information
12.9.2 VECOL Brucella Abortus Vaccine Product Offered
12.9.3 VECOL Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 VECOL Main Business Overview
12.9.5 VECOL Latest Developments
12.10 Tecnovax
12.10.1 Tecnovax Company Information
12.10.2 Tecnovax Brucella Abortus Vaccine Product Offered
12.10.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Tecnovax Main Business Overview
12.10.5 Tecnovax Latest Developments
12.11 Indian Immunologicals
12.11.1 Indian Immunologicals Company Information
12.11.2 Indian Immunologicals Brucella Abortus Vaccine Product Offered
12.11.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Indian Immunologicals Main Business Overview
12.11.5 Indian Immunologicals Latest Developments
12.12 Vetal
12.12.1 Vetal Company Information
12.12.2 Vetal Brucella Abortus Vaccine Product Offered
12.12.3 Vetal Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Vetal Main Business Overview
12.12.5 Vetal Latest Developments
12.13 Dollvet
12.13.1 Dollvet Company Information
12.13.2 Dollvet Brucella Abortus Vaccine Product Offered
12.13.3 Dollvet Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Dollvet Main Business Overview
12.13.5 Dollvet Latest Developments
12.14 Centro Diagnostico Veterinario
12.14.1 Centro Diagnostico Veterinario Company Information
12.14.2 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Offered
12.14.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Centro Diagnostico Veterinario Main Business Overview
12.14.5 Centro Diagnostico Veterinario Latest Developments
12.15 Onderstepoort Biological Products
12.15.1 Onderstepoort Biological Products Company Information
12.15.2 Onderstepoort Biological Products Brucella Abortus Vaccine Product Offered
12.15.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Onderstepoort Biological Products Main Business Overview
12.15.5 Onderstepoort Biological Products Latest Developments
12.16 Institute of Animal Health and Veterinary Biologicals
12.16.1 Institute of Animal Health and Veterinary Biologicals Company Information
12.16.2 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Offered
12.16.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Institute of Animal Health and Veterinary Biologicals Main Business Overview
12.16.5 Institute of Animal Health and Veterinary Biologicals Latest Developments
12.17 Biogenesis Bago
12.17.1 Biogenesis Bago Company Information
12.17.2 Biogenesis Bago Brucella Abortus Vaccine Product Offered
12.17.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Biogenesis Bago Main Business Overview
12.17.5 Biogenesis Bago Latest Developments
12.18 Instituto Rosenbusch
12.18.1 Instituto Rosenbusch Company Information
12.18.2 Instituto Rosenbusch Brucella Abortus Vaccine Product Offered
12.18.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Instituto Rosenbusch Main Business Overview
12.18.5 Instituto Rosenbusch Latest Developments
12.19 SYVA Laboratorios
12.19.1 SYVA Laboratorios Company Information
12.19.2 SYVA Laboratorios Brucella Abortus Vaccine Product Offered
12.19.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 SYVA Laboratorios Main Business Overview
12.19.5 SYVA Laboratorios Latest Developments
12.20 CZ Veterinaria
12.20.1 CZ Veterinaria Company Information
12.20.2 CZ Veterinaria Brucella Abortus Vaccine Product Offered
12.20.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 CZ Veterinaria Main Business Overview
12.20.5 CZ Veterinaria Latest Developments
12.21 Hester Biosciences
12.21.1 Hester Biosciences Company Information
12.21.2 Hester Biosciences Brucella Abortus Vaccine Product Offered
12.21.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 Hester Biosciences Main Business Overview
12.21.5 Hester Biosciences Latest Developments
12.22 Qilu Animal Health
12.22.1 Qilu Animal Health Company Information
12.22.2 Qilu Animal Health Brucella Abortus Vaccine Product Offered
12.22.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.22.4 Qilu Animal Health Main Business Overview
12.22.5 Qilu Animal Health Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Brucella Abortus Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of DNA Vaccines
Table 3. Major Players of Subunit Vaccines
Table 4. Major Players of Vector Vaccines
Table 5. Major Players of B. Abortus Recombinant Mutants
Table 6. Major Players of Others
Table 7. Global Brucella Abortus Vaccine Sales by Type (2016-2021) & (K Units)
Table 8. Global Brucella Abortus Vaccine Sales Market Share by Type (2016-2021)
Table 9. Global Brucella Abortus Vaccine Revenue by Type (2016-2021) & ($ million)
Table 10. Global Brucella Abortus Vaccine Revenue Market Share by Type (2016-2021)
Table 11. Global Brucella Abortus Vaccine Sale Price by Type (2016-2021)
Table 12. Global Brucella Abortus Vaccine Sales by Application (2016-2021) & (K Units)
Table 13. Global Brucella Abortus Vaccine Sales Market Share by Application (2016-2021)
Table 14. Global Brucella Abortus Vaccine Value by Application (2016-2021)
Table 15. Global Brucella Abortus Vaccine Revenue Market Share by Application (2016-2021)
Table 16. Global Brucella Abortus Vaccine Sale Price by Application (2016-2021)
Table 17. Global Brucella Abortus Vaccine Sales by Company (2019-2021) & (K Units)
Table 18. Global Brucella Abortus Vaccine Sales Market Share by Company (2019-2021)
Table 19. Global Brucella Abortus Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Brucella Abortus Vaccine Revenue Market Share by Company (2019-2021)
Table 21. Global Brucella Abortus Vaccine Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Brucella Abortus Vaccine Producing Area Distribution and Sales Area
Table 23. Players Brucella Abortus Vaccine Products Offered
Table 24. Brucella Abortus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Brucella Abortus Vaccine Sales by Region (2016-2021) (K Units)
Table 28. Global Brucella Abortus Vaccine Sales Market Share by Region (2016-2021)
Table 29. Global Brucella Abortus Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Brucella Abortus Vaccine Revenue Market Share by Region (2016-2021)
Table 31. Americas Brucella Abortus Vaccine Sales by Country (2016-2021) & (K Units)
Table 32. Americas Brucella Abortus Vaccine Sales Market Share by Country (2016-2021)
Table 33. Americas Brucella Abortus Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Brucella Abortus Vaccine Revenue Market Share by Country (2016-2021)
Table 35. Americas Brucella Abortus Vaccine Sales by Type (2016-2021) & (K Units)
Table 36. Americas Brucella Abortus Vaccine Sales Market Share by Type (2016-2021)
Table 37. Americas Brucella Abortus Vaccine Sales by Application (2016-2021) & (K Units)
Table 38. Americas Brucella Abortus Vaccine Sales Market Share by Application (2016-2021)
Table 39. APAC Brucella Abortus Vaccine Sales by Region (2016-2021) & (K Units)
Table 40. APAC Brucella Abortus Vaccine Sales Market Share by Region (2016-2021)
Table 41. APAC Brucella Abortus Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Brucella Abortus Vaccine Revenue Market Share by Region (2016-2021)
Table 43. APAC Brucella Abortus Vaccine Sales by Type (2016-2021) & (K Units)
Table 44. APAC Brucella Abortus Vaccine Sales Market Share by Type (2016-2021)
Table 45. APAC Brucella Abortus Vaccine Sales by Application (2016-2021) & (K Units)
Table 46. APAC Brucella Abortus Vaccine Sales Market Share by Application (2016-2021)
Table 47. Europe Brucella Abortus Vaccine Sales by Country (2016-2021) & (K Units)
Table 48. Europe Brucella Abortus Vaccine Sales Market Share by Country (2016-2021)
Table 49. Europe Brucella Abortus Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Brucella Abortus Vaccine Revenue Market Share by Country (2016-2021)
Table 51. Europe Brucella Abortus Vaccine Sales by Type (2016-2021) & (K Units)
Table 52. Europe Brucella Abortus Vaccine Sales Market Share by Type (2016-2021)
Table 53. Europe Brucella Abortus Vaccine Sales by Application (2016-2021) & (K Units)
Table 54. Europe Brucella Abortus Vaccine Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Brucella Abortus Vaccine Sales by Country (2016-2021) & (K Units)
Table 56. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Brucella Abortus Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Brucella Abortus Vaccine Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Brucella Abortus Vaccine Sales by Type (2016-2021) & (K Units)
Table 60. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Brucella Abortus Vaccine Sales by Application (2016-2021) & (K Units)
Table 62. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Application (2016-2021)
Table 63. Global Brucella Abortus Vaccine Sales Forecast by Type (2021-2026) & (K Units)
Table 64. Global Brucella Abortus Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 65. Global Brucella Abortus Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 66. Global Brucella Abortus Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 67. Global Brucella Abortus Vaccine Sales Forecast by Application (2021-2026) & (K Units)
Table 68. Global Brucella Abortus Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 69. Global Brucella Abortus Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 70. Global Brucella Abortus Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 71. Zoetis Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 72. Zoetis Brucella Abortus Vaccine Product Offered
Table 73. Zoetis Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 74. Zoetis Main Business
Table 75. Zoetis Latest Developments
Table 76. CEVA Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 77. CEVA Brucella Abortus Vaccine Product Offered
Table 78. CEVA Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 79. CEVA Main Business
Table 80. CEVA Latest Developments
Table 81. Merck Animal Health Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck Animal Health Brucella Abortus Vaccine Product Offered
Table 83. Merck Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 84. Merck Animal Health Main Business
Table 85. Merck Animal Health Latest Developments
Table 86. Biovet Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Biovet Brucella Abortus Vaccine Product Offered
Table 88. Biovet Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 89. Biovet Main Business
Table 90. Biovet Latest Developments
Table 91. CAVAC Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. CAVAC Brucella Abortus Vaccine Product Offered
Table 93. CAVAC Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 94. CAVAC Main Business
Table 95. CAVAC Latest Developments
Table 96. JOVAC Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. JOVAC Brucella Abortus Vaccine Product Offered
Table 98. JOVAC Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 99. JOVAC Main Business
Table 100. JOVAC Latest Developments
Table 101. Merial Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. Merial Brucella Abortus Vaccine Product Offered
Table 103. Merial Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 104. Merial Main Business
Table 105. Merial Latest Developments
Table 106. Colorado Serum Company Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. Colorado Serum Company Brucella Abortus Vaccine Product Offered
Table 108. Colorado Serum Company Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 109. Colorado Serum Company Main Business
Table 110. Colorado Serum Company Latest Developments
Table 111. VECOL Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. VECOL Brucella Abortus Vaccine Product Offered
Table 113. VECOL Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 114. VECOL Main Business
Table 115. VECOL Latest Developments
Table 116. Tecnovax Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. Tecnovax Brucella Abortus Vaccine Product Offered
Table 118. Tecnovax Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 119. Tecnovax Main Business
Table 120. Tecnovax Latest Developments
Table 121. Indian Immunologicals Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. Indian Immunologicals Brucella Abortus Vaccine Product Offered
Table 123. Indian Immunologicals Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 124. Indian Immunologicals Main Business
Table 125. Indian Immunologicals Latest Developments
Table 126. Vetal Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. Vetal Brucella Abortus Vaccine Product Offered
Table 128. Vetal Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 129. Vetal Main Business
Table 130. Vetal Latest Developments
Table 131. Dollvet Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. Dollvet Brucella Abortus Vaccine Product Offered
Table 133. Dollvet Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 134. Dollvet Main Business
Table 135. Dollvet Latest Developments
Table 136. Centro Diagnostico Veterinario Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 137. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Offered
Table 138. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 139. Centro Diagnostico Veterinario Main Business
Table 140. Centro Diagnostico Veterinario Latest Developments
Table 141. Onderstepoort Biological Products Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 142. Onderstepoort Biological Products Brucella Abortus Vaccine Product Offered
Table 143. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 144. Onderstepoort Biological Products Main Business
Table 145. Onderstepoort Biological Products Latest Developments
Table 146. Institute of Animal Health and Veterinary Biologicals Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 147. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Offered
Table 148. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 149. Institute of Animal Health and Veterinary Biologicals Main Business
Table 150. Institute of Animal Health and Veterinary Biologicals Latest Developments
Table 151. Biogenesis Bago Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 152. Biogenesis Bago Brucella Abortus Vaccine Product Offered
Table 153. Biogenesis Bago Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 154. Biogenesis Bago Main Business
Table 155. Biogenesis Bago Latest Developments
Table 156. Instituto Rosenbusch Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 157. Instituto Rosenbusch Brucella Abortus Vaccine Product Offered
Table 158. Instituto Rosenbusch Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 159. Instituto Rosenbusch Main Business
Table 160. Instituto Rosenbusch Latest Developments
Table 161. SYVA Laboratorios Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 162. SYVA Laboratorios Brucella Abortus Vaccine Product Offered
Table 163. SYVA Laboratorios Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 164. SYVA Laboratorios Main Business
Table 165. SYVA Laboratorios Latest Developments
Table 166. CZ Veterinaria Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 167. CZ Veterinaria Brucella Abortus Vaccine Product Offered
Table 168. CZ Veterinaria Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 169. CZ Veterinaria Main Business
Table 170. CZ Veterinaria Latest Developments
Table 171. Hester Biosciences Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 172. Hester Biosciences Brucella Abortus Vaccine Product Offered
Table 173. Hester Biosciences Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 174. Hester Biosciences Main Business
Table 175. Hester Biosciences Latest Developments
Table 176. Qilu Animal Health Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 177. Qilu Animal Health Brucella Abortus Vaccine Product Offered
Table 178. Qilu Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 179. Qilu Animal Health Main Business
Table 180. Qilu Animal Health Latest Developments
List of Figures
Figure 1. Picture of Brucella Abortus Vaccine
Figure 2. Brucella Abortus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brucella Abortus Vaccine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Brucella Abortus Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Brucella Abortus Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of DNA Vaccines
Figure 10. Product Picture of Subunit Vaccines
Figure 11. Product Picture of Vector Vaccines
Figure 12. Product Picture of B. Abortus Recombinant Mutants
Figure 13. Product Picture of Others
Figure 14. Global Brucella Abortus Vaccine Sales Market Share by Type in 2020
Figure 15. Global Brucella Abortus Vaccine Revenue Market Share by Type (2016-2021)
Figure 16. Brucella Abortus Vaccine Consumed in Cattles
Figure 17. Global Brucella Abortus Vaccine Market: Cattles (2016-2021) & (K Units)
Figure 18. Brucella Abortus Vaccine Consumed in Sheep
Figure 19. Global Brucella Abortus Vaccine Market: Sheep (2016-2021) & (K Units)
Figure 20. Brucella Abortus Vaccine Consumed in Pigs
Figure 21. Global Brucella Abortus Vaccine Market: Pigs (2016-2021) & (K Units)
Figure 22. Brucella Abortus Vaccine Consumed in Others
Figure 23. Global Brucella Abortus Vaccine Market: Others (2016-2021) & (K Units)
Figure 24. Global Brucella Abortus Vaccine Sales Market Share by Application (2016-2021)
Figure 25. Global Brucella Abortus Vaccine Revenue Market Share by Application in 2020
Figure 26. Global Brucella Abortus Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 27. Global Brucella Abortus Vaccine Revenue Market Share by Company in 2020
Figure 28. Global Brucella Abortus Vaccine Sales Market Share by Regions (2016-2021)
Figure 29. Global Brucella Abortus Vaccine Revenue Market Share by Region in 2020
Figure 30. Americas Brucella Abortus Vaccine Sales 2016-2021 (K Units)
Figure 31. Americas Brucella Abortus Vaccine Revenue 2016-2021 ($ Millions)
Figure 32. APAC Brucella Abortus Vaccine Sales 2016-2021 (K Units)
Figure 33. APAC Brucella Abortus Vaccine Revenue 2016-2021 ($ Millions)
Figure 34. Europe Brucella Abortus Vaccine Sales 2016-2021 (K Units)
Figure 35. Europe Brucella Abortus Vaccine Revenue 2016-2021 ($ Millions)
Figure 36. Middle East & Africa Brucella Abortus Vaccine Sales 2016-2021 (K Units)
Figure 37. Middle East & Africa Brucella Abortus Vaccine Revenue 2016-2021 ($ Millions)
Figure 38. Americas Brucella Abortus Vaccine Sales Market Share by Country in 2020
Figure 39. Americas Brucella Abortus Vaccine Revenue Market Share by Country in 2020
Figure 40. Americas Brucella Abortus Vaccine Sales Market Share by Type in 2020
Figure 41. Americas Brucella Abortus Vaccine Sales Market Share by Application in 2020
Figure 42. United States Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 43. Canada Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 44. Mexico Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Brazil Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. APAC Brucella Abortus Vaccine Sales Market Share by Region in 2020
Figure 47. APAC Brucella Abortus Vaccine Revenue Market Share by Regions in 2020
Figure 48. APAC Brucella Abortus Vaccine Sales Market Share by Type in 2020
Figure 49. APAC Brucella Abortus Vaccine Sales Market Share by Application in 2020
Figure 50. China Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Japan Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 52. Korea Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 53. Southeast Asia Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 54. India Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 55. Australia Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. Europe Brucella Abortus Vaccine Sales Market Share by Country in 2020
Figure 57. Europe Brucella Abortus Vaccine Revenue Market Share by Country in 2020
Figure 58. Europe Brucella Abortus Vaccine Sales Market Share by Type in 2020
Figure 59. Europe Brucella Abortus Vaccine Sales Market Share by Application in 2020
Figure 60. Germany Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 61. France Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 62. UK Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 63. Italy Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 64. Russia Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Country in 2020
Figure 66. Middle East & Africa Brucella Abortus Vaccine Revenue Market Share by Country in 2020
Figure 67. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Type in 2020
Figure 68. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Application in 2020
Figure 69. Egypt Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 70. South Africa Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 71. Israel Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 72. Turkey Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 73. GCC Country Brucella Abortus Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles


★調査レポート[世界のブルセラアボルタスワクチン市場予測 2021年-2026年] (コード：LPI21MY9458)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のブルセラアボルタスワクチン市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のBCGワクチン販売市場予測 2021年-2026年
    LPI21MY9436 / LP Information / 2021年5月 / LPインフォメーション社の「BCGワクチン販売の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、免疫BCG、治療BCGなど、用途別には、小児科、成人などにセグメント区分してまとめました。BCGワクチン販売のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・BCGワクチン販売の世界市場概要（サマリー） ・BCGワクチン販売の企業別販売量・売上 ・BCGワクチン販売の企業別市場シェア ・BCGワクチン販売の世界市場規模 2016年-2021年：種類別（免疫BCG、治療BCG） ・BCGワクチン販売の世界市場規模 2016年-2021年：用途別（小児科、成人） ・BCGワクチン販売の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・BCGワクチン販売のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of BCG Vaccine Sales will have significant change from previous year. By the most conservative estimates of global BCG Vaccine Sales market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the BCG Vaccine Sales market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine Sales market by product type,...
  • 世界のダニ媒介性脳炎ワクチン市場予測 2021年-2026年
    LPI21MY9672 / LP Information / 2021年5月 / LPインフォメーション社の「ダニ媒介性脳炎ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルスなど、用途別には、小児用ワクチン、成人用ワクチン、旅行者用ワクチンなどにセグメント区分してまとめました。ダニ媒介性脳炎ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ダニ媒介性脳炎ワクチンの世界市場概要（サマリー） ・ダニ媒介性脳炎ワクチンの企業別販売量・売上 ・ダニ媒介性脳炎ワクチンの企業別市場シェア ・ダニ媒介性脳炎ワクチンの世界市場規模 2016年-2021年：種類別（ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルス） ・ダニ媒介性脳炎ワクチンの世界市場規模 2016年-2021年：用途別（小児用ワクチン、成人用ワクチン、旅行者用ワクチン） ・ダニ媒介性脳炎ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ダニ媒介性脳炎ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Tick-borne Encephalitis Vaccine will have significant change from previous year. By the most conservative estimates of global Tick-borne Encephalitis Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Tick-borne Encephalitis Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Tick-borne Encephalitis Vaccine market by product type,...
  • 世界の23価肺炎球菌ワクチン市場予測 2021年-2026年
    LPI21MY9699 / LP Information / 2021年5月 / LPインフォメーション社の「23価肺炎球菌ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、単回投与バイアル、プレフィルドシリンジなど、用途別には、慢性心血管疾患、慢性肺疾患、慢性肝疾患、ヒト免疫不全ウイルス、白血病、リンパ腫、多発性骨髄腫、一般悪性腫瘍、慢性腎臓病、その他などにセグメント区分してまとめました。23価肺炎球菌ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・23価肺炎球菌ワクチンの世界市場概要（サマリー） ・23価肺炎球菌ワクチンの企業別販売量・売上 ・23価肺炎球菌ワクチンの企業別市場シェア ・23価肺炎球菌ワクチンの世界市場規模 2016年-2021年：種類別（単回投与バイアル、プレフィルドシリンジ） ・23価肺炎球菌ワクチンの世界市場規模 2016年-2021年：用途別（慢性心血管疾患、慢性肺疾患、慢性肝疾患、ヒト免疫不全ウイルス、白血病、リンパ腫、多発性骨髄腫、一般悪性腫瘍、慢性腎臓病、その他） ・23価肺炎球菌ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・23価肺炎球菌ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of 23-valent Pneumococcal Vaccine will have significant change from previous year. By the most conservative estimates of global 23-valent Pneumococcal Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the 23-valent Pneumococcal Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of 23-valent Pneumococcal Vaccine market by product type,...
  • 世界のプレフィルドワクチンシリンジ市場予測 2021年-2026年
    LPI21MY9005 / LP Information / 2021年5月 / LPインフォメーション社の「プレフィルドワクチンシリンジの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、針付き、針なしなど、用途別には、病院、診療所などにセグメント区分してまとめました。プレフィルドワクチンシリンジのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・プレフィルドワクチンシリンジの世界市場概要（サマリー） ・プレフィルドワクチンシリンジの企業別販売量・売上 ・プレフィルドワクチンシリンジの企業別市場シェア ・プレフィルドワクチンシリンジの世界市場規模 2016年-2021年：種類別（針付き、針なし） ・プレフィルドワクチンシリンジの世界市場規模 2016年-2021年：用途別（病院、診療所） ・プレフィルドワクチンシリンジの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・プレフィルドワクチンシリンジのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Prefilled Vaccine Syringes will have significant change from previous year. By the most conservative estimates of global Prefilled Vaccine Syringes market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Prefilled Vaccine Syringes market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Prefilled Vaccine Syringes market by product type,...
  • 世界の脳炎ワクチン市場予測 2021年-2026年
    LPI21MY9516 / LP Information / 2021年5月 / LPインフォメーション社の「脳炎ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、Nakayama、Beijing、P-3、SA 14-14-2など、用途別には、子供、大人などにセグメント区分してまとめました。脳炎ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・脳炎ワクチンの世界市場概要（サマリー） ・脳炎ワクチンの企業別販売量・売上 ・脳炎ワクチンの企業別市場シェア ・脳炎ワクチンの世界市場規模 2016年-2021年：種類別（Nakayama、Beijing、P-3、SA 14-14-2） ・脳炎ワクチンの世界市場規模 2016年-2021年：用途別（子供、大人）...According to this latest study, the 2020 growth of Encephalitis Vaccine will have significant change from previous year. By the most conservative estimates of global Encephalitis Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1127.9 million in 2019. Over the next five years the Encephalitis Vaccine market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 1413.7 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Encephalitis Vaccine market by product type, application, key manufacturers and...
  • 世界のワクチンコールドボックス市場予測 2021年-2026年
    LPI21MY9323 / LP Information / 2021年5月 / LPインフォメーション社の「ワクチンコールドボックスの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、5リットル以下、5〜15リットル、15〜25リットル、その他など、用途別には、ワクチン、インスリン、バイオ医薬品、IVD製品、生体試料、その他などにセグメント区分してまとめました。ワクチンコールドボックスのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ワクチンコールドボックスの世界市場概要（サマリー） ・ワクチンコールドボックスの企業別販売量・売上 ・ワクチンコールドボックスの企業別市場シェア ・ワクチンコールドボックスの世界市場規模 2016年-2021年：種類別（5リットル以下、5〜15リットル、15〜25リットル、その他） ・ワクチンコールドボックスの世界市場規模 2016年-2021年：用途別（ワクチン、インスリン、バイオ医薬品、IVD製品、生体試料、その他） ・ワクチンコールドボックスの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ワクチンコールドボックスのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Vaccine Cold Boxes will have significant change from previous year. By the most conservative estimates of global Vaccine Cold Boxes market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Vaccine Cold Boxes market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Cold Boxes market by product type,...
  • 世界の樹状細胞がんワクチン市場予測 2021年-2026年
    LPI21MY9503 / LP Information / 2021年5月 / LPインフォメーション社の「樹状細胞がんワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、クレアVax、シプリューセル-T（プロベンジ）、その他など、用途別には、小児、成人などにセグメント区分してまとめました。樹状細胞がんワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・樹状細胞がんワクチンの世界市場概要（サマリー） ・樹状細胞がんワクチンの企業別販売量・売上 ・樹状細胞がんワクチンの企業別市場シェア ・樹状細胞がんワクチンの世界市場規模 2016年-2021年：種類別（クレアVax、シプリューセル-T（プロベンジ）、その他） ・樹状細胞がんワクチンの世界市場規模 2016年-2021年：用途別（小児、成人） ・樹状細胞がんワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・樹状細胞がんワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Dendritic Cell Cancer Vaccine will have significant change from previous year. By the most conservative estimates of global Dendritic Cell Cancer Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Dendritic Cell Cancer Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Dendritic Cell Cancer Vaccine...
  • 世界の13価肺炎球菌多糖結合型ワクチン（PCV13）市場予測 2021年-2026年
    LPI21MY9698 / LP Information / 2021年5月 / LPインフォメーション社の「13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、血清型6B、7F血清型、血清型9V、14血清型、血清型18C、血清型19A、19F血清型、23F血清型、24F血清型など、用途別には、生後6週間-15ヶ月乳児、15ヶ月-5歳子供などにセグメント区分してまとめました。13価肺炎球菌多糖結合型ワクチン（PCV13）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場概要（サマリー） ・13価肺炎球菌多糖結合型ワクチン（PCV13）の企業別販売量・売上 ・13価肺炎球菌多糖結合型ワクチン（PCV13）の企業別市場シェア ・13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場規模 2016年-2021年：種類別（血清型6B、7F血清型、血清型9V、14血清型、血清型18C、血清型19A、19F血清型、23F血清型、24F血清型） ・13価肺炎球菌多糖結合型ワクチン（PCV13）の世界市場規模 2016年-2021年：用途別（生後6週間-15ヶ月乳児、15ヶ月-5歳子供） ・13価肺炎球菌多糖結合型ワクチン（PCV13）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・13価肺炎球菌多糖結合型ワクチン（PCV13）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) will have significant change from previous year. By the most conservative estimates of global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth...
  • 世界の新型コロナウイルスワクチン用ガラス瓶市場予測 2021年-2026年
    LPI21MY9389 / LP Information / 2021年5月 / LPインフォメーション社の「新型コロナウイルスワクチン用ガラス瓶の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、中ホウ酸塩ホウケイ酸ガラス、低ホウ酸塩ホウケイ酸ガラスなど、用途別には、ワクチン製造、ワクチン研究などにセグメント区分してまとめました。新型コロナウイルスワクチン用ガラス瓶のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・新型コロナウイルスワクチン用ガラス瓶の世界市場概要（サマリー） ・新型コロナウイルスワクチン用ガラス瓶の企業別販売量・売上 ・新型コロナウイルスワクチン用ガラス瓶の企業別市場シェア ・新型コロナウイルスワクチン用ガラス瓶の世界市場規模 2016年-2021年：種類別（中ホウ酸塩ホウケイ酸ガラス、低ホウ酸塩ホウケイ酸ガラス） ・新型コロナウイルスワクチン用ガラス瓶の世界市場規模 2016年-2021年：用途別（ワクチン製造、ワクチン研究） ・新型コロナウイルスワクチン用ガラス瓶の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・新型コロナウイルスワクチン用ガラス瓶のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Vials for COVID-19 Vaccine will have significant change from previous year. By the most conservative estimates of global Vials for COVID-19 Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vials for COVID-19 Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Vials for COVID-19 Vaccine...
  • 世界のジフテリア・百日咳・破傷風ワクチン市場予測 2021年-2026年
    LPI21MY1209 / LP Information / 2021年5月 / LPインフォメーション社の「ジフテリア・百日咳・破傷風ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、DTaP、Td、Tdapなど、用途別には、病院、クリニック、予防接種センターなどにセグメント区分してまとめました。ジフテリア・百日咳・破傷風ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ジフテリア・百日咳・破傷風ワクチンの世界市場概要（サマリー） ・ジフテリア・百日咳・破傷風ワクチンの企業別販売量・売上 ・ジフテリア・百日咳・破傷風ワクチンの企業別市場シェア ・ジフテリア・百日咳・破傷風ワクチンの世界市場規模 2016年-2021年：種類別（DTaP、Td、Tdap） ・ジフテリア・百日咳・破傷風ワクチンの世界市場規模 2016年-2021年：用途別（病院、クリニック、予防接種センター） ・ジフテリア・百日咳・破傷風ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ジフテリア・百日咳・破傷風ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Diphtheria, Pertussis, and Tetanus Vaccine will have significant change from previous year. By the most conservative estimates of global Diphtheria, Pertussis, and Tetanus Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2467.1 million in 2019. Over the next five years the Diphtheria, Pertussis, and Tetanus Vaccine market will register a 4.0% CAGR in terms of revenue, the global market size will reach US$ 2886.2 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Diphtheria,...

    • ◆H&Iグローバルリサーチのお客様（例）◆